Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
05/25/2011 | CN101328169B Diethylcarbamyl-substituted thiazole dihydropyrimidine |
05/25/2011 | CN101272783B (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor |
05/25/2011 | CN101213184B Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
05/24/2011 | US7947830 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
05/24/2011 | US7947713 Tripeptidyl peptidase inhibitors |
05/24/2011 | US7947711 Bicyclic-substituted amines as histamine-3 receptor ligands |
05/24/2011 | US7947700 Carboxylic acid amides, the preparation thereof and their use as medicaments |
05/24/2011 | US7947683 3-(1,2,4-triazol-3-ylalkyl) azabicyclo (3.1.0) hexane derivatives as modulators of dopamine D3 receptors |
05/24/2011 | CA2499690C Diaryl ethers as opioid receptor antagonist |
05/24/2011 | CA2493026C Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridines |
05/24/2011 | CA2490888C Diaminopyrimidinecarboxamide derivative |
05/24/2011 | CA2477601C 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
05/24/2011 | CA2467552C Nicotin-or isonicotin benzothiazole derivatives |
05/19/2011 | WO2011060000A1 Hepatitis c virus inhibitors |
05/19/2011 | WO2011059042A1 Aromatic ring compound |
05/19/2011 | WO2011058963A1 1-heterodiene derivative and noxious organism control agent |
05/19/2011 | WO2011058766A1 Aryl carboxamide derivatives as ttx-s blockers |
05/19/2011 | WO2011058763A1 Aminothiazine or aminooxazine derivative having amino linker |
05/19/2011 | WO2011058139A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
05/19/2011 | WO2011057973A1 Oxazoline derivatives for treatment of cns disorders |
05/19/2011 | WO2011057892A1 2,3-dihydrobenzoxazine and 2,3-dihydrobenzothiazine derivates as hif-inhibitors for the treatment of cancer and inflammatory diseases |
05/19/2011 | WO2011057805A1 Tubulin inhibitors |
05/19/2011 | WO2011017342A3 Mesoionic pesticides |
05/19/2011 | WO2011015524A3 Fungicide heterocycles derivatives |
05/19/2011 | WO2010111634A3 Renin inhibitors |
05/19/2011 | US20110118470 Nitrogen-containing aromatic derivatives |
05/19/2011 | US20110118460 Process for the synthesis of quetiapine |
05/19/2011 | US20110118314 Piperidine analogs as glycogen synthase activators |
05/19/2011 | US20110118311 Azole compound |
05/19/2011 | US20110118282 Soluble Guanylate Cyclase Activators |
05/19/2011 | US20110118281 Compounds for inflammation and immune-related uses |
05/19/2011 | US20110118260 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group |
05/19/2011 | US20110118248 Heteroaryl sulfonamides and CCR2/CCR9 |
05/19/2011 | US20110118246 Novel Compounds |
05/19/2011 | US20110118245 Raf kinase modulator compounds and methods of use thereof |
05/19/2011 | US20110118241 6-Pyridin-3-YL-3,4-Dihydro-1H-Quinolin-2-One Derivatives and Related Compounds as Inhibitors of the Human Aldosterone Synthase CYP11B2 |
05/19/2011 | US20110118236 Heterocyclic compound |
05/19/2011 | US20110118232 Pyrimidine compounds and use thereof |
05/19/2011 | US20110117591 Chemical probe compounds that become fluorescent upon reduction, and methods for their use |
05/19/2011 | US20110117055 Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds |
05/19/2011 | CA2780772A1 Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
05/19/2011 | CA2780682A1 1-heterodiene derivative and pest control agent |
05/19/2011 | CA2780641A1 Selective heterocyclic sphingosine 1 phosphate receptor modulators |
05/19/2011 | CA2780568A1 Oxazoline derivatives for treatment of cns disorders |
05/19/2011 | CA2780031A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
05/18/2011 | EP2322520A1 Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia |
05/18/2011 | EP2322516A1 Intermediates for the preparation of Macrocyclic inhibitors of hepatitis c virus |
05/18/2011 | EP2321862A1 Organic semiconductor material and light-emitting element, light-emitting device, lighting system, and electronic device using the same |
05/18/2011 | EP2321309A1 Benzothiazoles and aza-analogues thereof use as antibacterial agents |
05/18/2011 | EP2321303A2 Compounds that modulate intracellular calcium |
05/18/2011 | EP2321296A1 Substituted 5-aminopyrazoles and use thereof |
05/18/2011 | EP2321289A1 Selective glycosidase inhibitors and uses thereof |
05/18/2011 | EP2321288A1 Oxazole derivatives useful as inhibitors of faah |
05/18/2011 | EP2321283A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors |
05/18/2011 | EP2321274A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
05/18/2011 | EP2320738A1 Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use |
05/18/2011 | EP2320737A1 Pyrazoloý1,5-a¨pyridines as mark inhibitors |
05/18/2011 | EP2099759B1 Antibacterial quinoline derivatives |
05/18/2011 | EP1667984B1 Gamma-secretase inhibitors |
05/18/2011 | EP1529053B1 Macrolide compounds endowed with antiinflammatory activity |
05/18/2011 | EP1467969B1 Dna minor groove binding compounds |
05/18/2011 | EP1373210B1 Heterocyclic diamide invertebrate pest control agents |
05/18/2011 | EP1318140B1 Novel amide derivatives and medicinal use thereof |
05/18/2011 | CN102066368A 1,2-benzisothiazole compounds useful for combating animal pests |
05/18/2011 | CN102066367A Thiazolyl piperdine derivatives |
05/18/2011 | CN102066366A Novel substituted pyridin-2-ones and pyridazin-3-ones |
05/18/2011 | CN102066365A Thiophene or thiazole derivatives and their use as PI3K inhibitors |
05/18/2011 | CN102066340A 2, 6-diamino-pyrimidin- 5-yl-carboxamides as SRK or JAK kinases inhibitors |
05/18/2011 | CN102066339A 2, 6-diamino- pyrimidin- 5-yl-carboxamides as SYK or JAK kinases inhibitors |
05/18/2011 | CN102066335A Substituted pyrimidin-5-carboxamides 281 |
05/18/2011 | CN102066326A Pyridone compound |
05/18/2011 | CN102066322A Compound having NPY Y5 receptor antagonist activity |
05/18/2011 | CN102060852A Quinoline complexes, preparation method thereof, quinoline complex-containing catalyst and use of catalyst in catalysis of vinyl polymerization |
05/18/2011 | CN102060772A N-(4-substituted phenyl)-1H-3-pyrazolecarboxamide cyclin dependent kinase 2 inhibitors and application thereof |
05/18/2011 | CN101189231B Novel cyclic aminophenylalkanoic acid derivative |
05/17/2011 | US7943803 Clathrate compound, method for controlling concentration of aqueous agricultural chemical active ingredient solution, and agricultural chemical formulation |
05/17/2011 | US7943777 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use |
05/17/2011 | US7943774 Heterocyclyl-substituted thiazoles as crop protection agents |
05/17/2011 | US7943768 Piperazine compounds useful as antagonists of C-C chemokines (Ccr2b and CcrS) for the treatment of inflammatory diseases |
05/17/2011 | US7943645 Piperidine compounds for use as orexin receptor antagonist |
05/17/2011 | US7943627 2,4-diaminopyrimidine derivatives |
05/17/2011 | US7943619 Isoxazolo-pyridazine derivatives |
05/17/2011 | US7943607 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
05/17/2011 | US7943605 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
05/17/2011 | CA2487840C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and their therapeutic application |
05/17/2011 | CA2473790C 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
05/17/2011 | CA2470365C 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
05/12/2011 | WO2011057054A1 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
05/12/2011 | WO2011056652A1 Imidazole derivatives as ido inhibitors |
05/12/2011 | WO2010093650A3 Compositions and methods for controlling nematodes |
05/12/2011 | WO2008079988A9 Quinazolines for pdk1 inhibition |
05/12/2011 | US20110112295 Tricyclic spacer systems for nonlinear optical devices |
05/12/2011 | US20110112290 process for the preparation of quetiapine |
05/12/2011 | US20110112154 Compounds, compositions and methods |
05/12/2011 | US20110112149 Epothilone analogues, their pharmaceutical compositions, their use and their prepa rations |
05/12/2011 | US20110112143 Allosteric modulators of metabotropic glutamate receptors |
05/12/2011 | US20110112142 Novel estrogen receptor ligands |
05/12/2011 | US20110112118 2,4-Diaminoquinazolines for Spinal Muscular Atrophy |
05/12/2011 | US20110112110 Antiproliferative compounds and therapeutic uses thereof |
05/12/2011 | US20110112103 5-hydroxypyrimidine-4-carboxamide compound |